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Abstract: Nanohydroxyapatite (n-HA)/zinc oxide (ZnO)
complex was synthesized by a direct precipitation meth-
od, and the antibacterial capability and antibacterial
mechanism of this complex were investigated in this arti-
cle. Transmission electron microscope (TEM), Fourier
transform infrared, X-ray photoelectronic spectroscopy
(XPS), and X-ray diffraction (XRD) were used to analyze
the materials. In addition, the antibacterial capacity of n-
HA/ZnO complex was examined by bacteriolytic plate,
inhibition effect, and antibacterial rate assays under light
or without light. Furthermore, agarose gel electrophoresis
of plasmid DNA (pUC18) was used to study biocidal
action of this complex. The results of TEM observation
revealed that the complex’s rods had a single crystalline
obelisk-like hexagonal wurtzite structure and the crystal
retained the nanometer size. XRD analysis indicated that
the phase of ZnO appeared and the lattice parameters of
n-HA and ZnO changed. XPS spectra showed that the
bonding energy of Ca, P, and O atoms changed in the
complex. The analyses also showed that the two phases
of ZnO and n-HA combined closely. Further, the results
of the antibacterial test revealed that this complex pos-
sessed strong antibacterial capability; the antibacterial
rate was 99.45% to S. aureus and 95.65% to E. coli under
light, respectively. The antibacterial activity of this com-
plex under light was better than without light, which was
attributed to the generation of OH under light. From the
agarose gel electrophoresis, the dissolving solution of this
complex could catalyze the cleavage of pUC18.  2007
Wiley Periodicals, Inc. J Biomed Mater Res 85A: 929–937,
2008
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INTRODUCTION
Clinical success of implants depends upon the
integration of a biomaterial device into the surround-
ing body tissues. In addition to the encouragement
of the cellular interactions, the biomaterial surface
has to discourage adhesion of infectious bacteria,
which are a common cause of implant failure.1,2 Poly-
methylmetacrylate (PMMA) loaded with antimicro-
bial agents is used for treatment and prevention of
orthopedic infections.3 Unfortunately, PMMA bone
cement is associated with several disadvantages, like
reducing biocompatibility with bone, short duration
of release, and thermal damage to the antibiotics.4
Therefore, in recent years, the use of inorganic anti-
bacterial biomaterials is highlighted for the control
of bacteria.5 The advantages of inorganic biomateri-
als are their safety, durability, and stability, com-
pared with organic antibacterial biomaterials.6
Zinc oxide (ZnO) is an inorganic material, which
processes unique properties such as nontoxicity
and antiseptic effect.7–10 ZnO has already been
studied extensively. Song et al. found that ZnO
exhibited antibacterial activity of E. coli.11 Another
inorganic material that has been used widely as
biomaterial is hydoxyapatite (HA) ceramic. This
material is known for its good biocompatibility and
bioactive bone behavior.12–15 Our intention is to
prepare a new anti-inﬂammatory biomaterial that
combines the favorable biological characteristics of
HA and possess antimicrobial activity as expressed
by ZnO.
In this article, a direct precipitation method was
used to prepare a ZnO bearing n-HA slurry with a
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nanometer-sized crystal size. The properties of this
complex were characterized and analyzed, using
XPS, IR, TEM, and XRD. Bacteriolytic plate, inhibi-
tion effect, and antibacterial rate assays were used to
measure the antibacterial activities of materials
against E. coli and S. aureus, and to discuss the anti-
bacterial mechanism.
MATERIALS AND METHODS
Preparation of the materials
n-HA slurry was synthesized by a precipitation
method.16 Zinc nitrate [Zn(NO3)26H2O], PEG-400, and
ammonia (25 wt %), purchased from Chengdu Chemical
Reagent Company, were of analytical grade. Firstly,
Zn(NO3)26H2O and PEG-400 powders were dissolved
into aqueous solution, and then ammonia was dropped
slowly into the solution with vigorous stirring. The drop-
ping speed was near 4 mL min1 and the reaction was
carried out in ambient condition. The rotation speed of
stirrer was adjusted to 1000 rpm. After titration, the pre-
cursor of Zn(OH)2 was introduced into n-HA slurry
according to the n-HA/ZnO weight ratio of 9:1, and then
kept stirring for 2 h. Then the obtained slurry was
shaken in ultrasonic instrument for 2 h and aged for
another 24 h. Finally, the white precipitate was fully
washed with deionized water and ethanol, respectively,
and dried at 808C. The obtained powder was calcined at
3008C for 2 h.
Characterization of materials
The content of Zn element in the n-HA/ZnO complex
was analyzed by Atom adsorption spectrometer (AAS,
VARIAN Spectr AA 220FS).
X-ray photoelectronic spectroscopy (XPS, XSAM 800)
was utilized to analyze the surface area of the powder.
Chemical analysis of the complex was carried out by a
Fourier transform infrared (FTIR) spectrophotometer
(Thermo Nicolet 170SX) in the range from 4000 to 400 cm1
at 2 cm1 resolution averaging 100 scans.
The microstructure of the n-HA/ZnO complex was
observed with a transmission electron microscope (TEM,
JME-100CX).
XRD was used to determine the structure of the mate-
rial. XRD analysis was performed with a DX-1000 analyzer
(Cu-Ka). The samples were measured in the 2h range from
108 to 708 (scan speed of 0.028 per second).
Antibacterial test
All antibacterial tests were performed with bacteria JM
no. 109 Escherichia coli (E. coli), ATCC no. 26003 Staphylo-
coccus aureus (S. aureus), supplied by Microbial Laboratory
of College of Life Science, Sichuan University, China.
Bacteriolytic plate assay
First, an inoculum with this strain was grown overnight
in 2 mL NB media (10 g/L Peptone, 5 g/L NaCl, 3 g/L
Beef extract) at 378C with shaking. Then, a soft agar-incu-
bation mixture was made containing 15 mL of 0.8% agar
previously melted at 458C with 50 lL of the bacterial cell
inoculums. The n-HA and n-HA/ZnO powder was put
into the shape of a disc (/ 12.5 3 2 mm2) under UV light
and without light irritation, then putting them on the soft-
agar layer. Finally, the plates were incubated at 378C for
24 h under light and without light, respectively. After
incubation, the inhibition zones were visually inspected
along the edge of ‘‘discs’’ and the plates were photo-
graphed. In this assay, all the data were the means of three
parallel experiments (d ¼3).
Inhibition effects assay
To determine the antibacterial activity, 0.1 mL diluted
bacterial suspension was cultured in 5 mL liquid NB me-
dium containing n-HA/ZnO complex for different periods.
The inoculated medium was maintained at 378C with
shaking. The number of bacteria was counted by ultra-vio-
let absorption of the cultured medium at 260 nm (A260).
All the data were the means of three parallel experiments
(d ¼3) of which the discrepancies were less than 5%.
Antibacterial rate assay
The antibacterial rate was calculated by the method of
counting lawn.17 Hundred microliters of an overnight cul-
ture of E. coli and S. aureus was diluted into 10 mL NB liq-
uid cultures, respectively. Then the liquid is transferred to
the sterile tube containing 1 g of specimen’s powder. The
tubes were incubated 24 h at 378C and the bacterial
growth was measured by optical density at 260 nm.
Interaction between dissolving solution of n-HA/
ZnO complex and plasmid DNA
Plasma DNA (pUC18) was distracted from E. coli (JM
no. 109) by alkaline lyses method.18 Ten microliters of
diluted pUC18 suspension was cultured in EP. Then, 10 lL
of the dissolved n-HA/ZnO complex was transferred into
EP and incubated at 378C without light. After 1, 5, 10, 15,
30, 60, and 300 min of incubation, 3 lL suspension was
extracted and assayed by agarose gel electrophoresis.
RESULTS AND DISCUSSION
XPS analysis
Figure 1 shows the XPS spectra of n-HA and n-
HA/ZnO complex. Figure 2 shows the XPS spec-
trum of Zn2P in n-HA/ZnO complex. From Figures
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1(b) and 2, it can be deduced that the binding energy
peak of Zn is at 1022.2 eV, which belongs to ZnO
according to Hoogewijs et al.,19 and Gaarenstroom
and Winograd.20 Besides, the binding energy of Ca,
P, and O atoms has some differences between n-HA
(Ca: 345.5 eV; O: 530.2 eV; P: 132.5 eV) and the com-
plex (Ca: 347.2 eV; O: 531.2 eV; P: 133.3eV). The val-
ues of elements in the complex are higher than those
of n-HA, which implies that some interaction or
chemical bonding may be formed between the two
phases, such as between Ca2þ, OH, PO4
3, and
Zn2þ in n-HA/ZnO complex.
IR analysis
IR spectra of n-HA and n-HA/ZnO complex pow-
der are shown in Figure 3(a,b). It can be seen that
the major bands of HA associated with PO4
3 (1094,
1036, 963, 604, and 566 cm1) and OH (3568 and
628 cm1) appear in Figure 3(b). The bands attrib-
uted to CO3
2 (1350–1450 cm1) and HPO4
 (873
cm1) also appeared in the spectra in Figure 3(a,b).
Kumar et al.21 report that B-type (CO3
2 for PO4
3)-
substituted HA is present. IR spectra also show that
there are some changes in the frequencies of PO4
3
and OH, shifting to the low wave numbers in the
complex, which is in agreement with XPS analysis.
Meanwhile, this movement indicates that the posi-
tive end of the OH dipole approaches the negative
Ca vacancies (Vca),22 which contributes to the wave
numbers shift. Besides, the sorption of Zn from ZnO
is probably favored by suitable O–O separation
between PO4
3 groups of HA,23 which is the biden-
tate coordination of Zn with PO4
3 tetrahedral, as
shown in Figure 4.
TEM observation
As shown in Figure 5, TEM micrograph illustrates
that the n-HA/ZnO complex possesses a uniform
and ultra ﬁne microstructure with an average grain
size of 80–90 nm in length and 15–30 nm in diame-
ter, with no glassy or amorphous interface along the
grain boundaries. Also, the ZnO grains combined
Figure 3. IR spectra of n-HA (a) and n-HA/ZnO complex
(b) powder calcined at 3008C.
Figure 1. XPS spectra of n-HA (a) and n-HA/ZnO com-
plex (b) powder calcined at 3008C.
Figure 2. XPS spectrum of Zn2P in the n-HA/ZnO com-
plex calcined at 3008C.
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with n-HA crystals without phase-separation. It can
also be seen that the complex is composed of well-
deﬁned crystals with an obelisk-like hexagonal wurt-
zite structure.
XRD analysis
According to XRD data calculated by Jade 6 soft-
ware, the mean size of n-HA is about 58.66 6 0.4
nm, and ZnO crystal is about 28.36 6 0.6 nm,
which is in agreement with the TEM observations.
This indicates also that the complex is a nanosized
material.
Figure 6 shows the appearance of the characteristic
ZnO peaks at 34.138, 38.488, 47.688, and 56.708 corre-
sponding to the (100), (002), (102), and (110) crystal
plane, which is comparative with the XRD pattern of
ZnO powder (JCPDS no. 36-1451). This suggests that
a ZnO phase forms in the complex.
On the other hand, the characteristic diffraction
peaks of n-HA located at 25.928, 31.948, 40.128,
47.018, and 48.738 [as shown in Fig. 6(a)] suggest
that HA retains its hexagonal structure. However,
the wide peaks of n-HA account to its poor crystalli-
zation. Further, the (100) peak of ZnO is overlapped
by the (121) peak of n-HA.
The results of XRD data (Table I) indicate a
decrease in the a axis and an increase in the c axis of
the HA unit cell after compounding. Moreover, the
2h degree of n-HA/ZnO decrease in the (004), (002)
crystal plain and increase in the (200), (300) plane
compared to those of n-HA. According to the
Smith–Lehrt formula, the same conclusion can be
made, i.e. the trends in the lattice parameters can be
largely attributed to the ion exchange. Moreover, the
content of ZnO is up to 7.54 wt % by AAS analysis,
whereas the theoretical value of ZnO is 10 wt %.
This difference implies that part of Zn2þ ion has not
formed Zn(OH)2, and enters into n-HA lattice. The
diameter of Zn2þ is smaller than that of Ca2þ,* and
so it causes a contraction in the a-axis and expansion
in c-axis dimensions in the complex compared to n-
HA. As we know, HA belongs to the hexagonal sys-
tem with a space group of P63/m. For B-type, the
charge compensation can take place by OH and
Figure 6. XRD patterns of n-HA (a) and n-HA/ZnO com-
plex (b) powder calcined at 3008C.
Figure 5. TEM photo of n-HA/ZnO complex.
Figure 4. Schematic model illustrating possible coordina-
tion bonding. [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
*Determined from the database JADE (Materials Data
Inc.).
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Ca vacancies.22,24 When Zn is substituted for Ca of
the n-HA, it may alter the balance of the charge
defect for the compensation system. Thus the a, b
lattice parameter was found to decrease by 0.11%,
whereas the c parameter changed little, only increas-
ing by 0.003% in the new system. Besides, the Zn of
ZnO coordinates with the O in PO4
3 of n-HA act as
a bridge to PO4
3 groups, which is another reason
for the occurrence of the changes in the n-HA unit
cell. On the other hand, some differences exist also
in the lattice parameters of ZnO in the complex com-
pared to the standard ZnO, which may also be
assigned to ion exchange and the bidentate coordina-
tion bonding between the ZnO and PO4
3 group.
Zn(II) interaction with HA had indicated different
mechanisms. Xu et al.25 and Lusvardi et al.26 sug-
gested that ion exchange was a possible mechanism
for the Zn bearing HA. Based on the discussion
above, it can be speculated that these lattice changes
may result from ion–ion, ion–dipole, and dipole–
dipole interaction, translation, rotation, and vibra-
tion. Accordingly, the possible effective geometry
can be schematically depicted as Figure 7.
Antibacterial capability assays
Table II illustrates the results of the bacteriolytic
plate assay. The results show that only the n-HA/
ZnO complex has an antibacterial effect on E. coli
and S. aureus.
Figures 8 and 9 show the inhibition effect of the
various materials at different concentrations on the
growth of E. coli and S. aureus. The absorbance at
260 nm (A260) characterizes the number of microor-
ganisms in the cultured medium.27 Lower absorb-
ance means a higher antibacterial effect of the mate-
rial. It can be seen that control II is only slightly dif-
ferent from that of the control I material after 24 h,
which have A260 values of 1.90 and 2.06, respec-
tively. This suggests that the n-HA has no inhibiting
effect on E. coli and S. aureus, while the n-HA/ZnO
complex shows high antibacterial activities against
S. aureus and E. coli at 24 h.
The antibacterial rates of both control I and control
II are zero suggesting no antibacterial activity. In
contrast, the antibacterial rates of the n-HA/ZnO
complex are evident, which is above 87% against
both E. coli and S. aureus (Table III).
Antibacterial mechanism
As stated above, the n-HA/ZnO complex shows a
good antibacterial activity, while pure n-HA has no
effect on E. coli and S. aureus, which suggests that
ZnO provides the complex with the antibacterial
property. This difference may associate with the
antibacterial mechanism of ZnO. Generally, there are
two kinds of theories to explain the antibacterial
mechanism of ZnO. The one holds that metal zinc
can react with water and release Zn2þ,28 which sub-
sequently decomposes the bacterium. The other
theory is based on light-catabolism29 and advocates
that ZnO generates activated oxygen (OH) under
light, especially under UV light. The OH combines
with sulfhydryl groups of the respiratory enzyme or
the nucleic acids in bacteria and stop the breath of
bacteria.
e and hþ will appear after UV irradiation, and
further form OH and O2.11 When OH comes in
contact with the cell, it may destroy the cell wall
and membrane, or interact with protein thiol groups,
causing the cytoplasm to run off and oxidizing the
cell nucleus, which ﬁnally induces the death of the
bacteria.30 O2 ions are the feasible chemical species
at the reduction of oxygen molecule. It is found that
the reduced oxygen plays as the antibacterial chemi-
cal species. According to the antibacterial theory, it
may be explained that the rates of the n-HA/ZnO
complex under light are higher than those without
light toward bacteria.
TABLE I
The Lattice Parameter and Crystal Size of n-HA, ZnOa and n-HA/ZnO Composites
Sample n-HA ZnOa n-HA/ZnO Composite
Lattice parameter (A˚) a ¼ b ¼ 9.4179,
c ¼ 6.8853
a ¼ b ¼ 3.2498,
c ¼ 5.2066
a ¼ b ¼ 9.4077,
c ¼ 6.8855
a ¼ b ¼ 3.2496,
c ¼ 5.2069
d-space (A˚) d(002) ¼ 3.4476 d(002) ¼ 3.4479
d(004) ¼ 1.7217 d(004) ¼ 1.7227
d(300) ¼ 2.7217 d(300) ¼ 2.7186
d(200) ¼ 4.0703 d(200) ¼ 3.8904
d(002) ¼ 2.6033 d(002) ¼ 2.6064
d(101) ¼ 2.4759 d(101) ¼ 2.4781
d(102) ¼ 1.9111 d(102) ¼ 1.9126
d(110) ¼ 1.6247 d(110) ¼ 1.6258
aFrom JCPDC database (No.: 89-0511).
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Tables II and III show that the n-HA/ZnO com-
plex is more effective for S. aureus whether under
light or not. Accumulating evidence shows that the
complex exerts a high antibacterial activity against
gram-positive but not gram-negative bacteria. The
outer membrane, covering the cytoplasmic mem-
brane and peptidoglycan layer of gram-negative bac-
teria, is composed of lipopolysaccharide (LPS),
which restricts antibacterial ions passing across the
outer membrane of gram-negative bacteria. On the
other hand, this complex is able to cause permeabili-
zation of both S. aureus and E. coli cytoplasmic mem-
branes. However, the level of permeability of S. aureus
cytoplasmic membrane is markedly higher than that
of E. coli. This may be due to the outer membrane
barrier of E. coli, which somewhat prohibits antibac-
terial ions accessing the cytoplasmic membrane.
Consequently, the n-HA/ZnO complex is more
effective for S. auerus than E. coli.
Besides, Figure 10 shows the effects of the n-HA/
ZnO complex on the cleavage of pUC18 extracted
from JM no. 109 after different incubation times.
TABLE II
Diameters of Bacterium Repress (in circle/mm)
E. coli S. aureus
Under Light No Light Under Light No Light
n-HA/ZnO composite 14.50 6 0.05 13.00 6 0.1 16.00 6 0.4 14.75 6 0.15
Control I 0 0 0 0
Control II 0 0 0 0
A control I assay was carried out without material, while control II assay was only n-HA powder.
Figure 7. Schematic model of structures: (a) n-HA; (b) CO3
2, HPO4
2 substituted n-HA; (c) ZnO occupying lattice sites of
n-HA; (d) O ZnO coordination bonding between ZnO and n-HA. [Color ﬁgure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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Form 2 does not appear in control I and control II,
which indicates that n-HA cannot accelerate the
plasmid DNA cleavage. On the other hand, DNA
cleavage would efﬁciently be accomplished by dis-
solving Zn2þ of n-HA/ZnO complex. As shown in
Figure 10, it can be deduced that with a prolong
reaction time, form 1 can be efﬁciently transformed
to form 2 at 300 min. As shown in the study, it
shows better DNA cleavage ability after combining
to ﬁltrate off the n-HA/ZnO complex. In this cata-
lytic cycle, the complex ﬁrst combined with DNA,
ZnO reacts with H2O, thus hydroxyl anion coordi-
nated to the metal Zinc may serve as nucleophilic re-
agent,31 as well as the Zn2þ activates the central
phosphorus atom. Then, it attacks the phosphorus
anion to form a transition state. Meanwhile, the
OH group of n-HA acts also as a nucleophilic rea-
gent and induces the complex to connect with other
sides of pUC18. This cooperative effect of n-HA and
ZnO catalyzes the hydrolysis of the 3,5-phosphate
diester bond in the DNA sequence. Finally, it breaks
up to complete the DNA cleavage (shown in Figure
11), inducing the changes of DNA and destroying
the bacteria.
Figure 8. Antibacterial activities of samples against E. coli
with the incubation time. A control I assay was carried out
when no material was added to the peptone solution. A
control II assay was carried out when only n-HA powder
was added to the peptone solution. The concentration of
the samples was 1 g/mL. [Color ﬁgure can be viewed in
the online issue, which is available at www.interscience.
wiley.com.]
Figure 9. Antibacterial activities of samples against
S. aureus with the incubation time. A control I assay was
carried out when no material was added to the peptone
solution. A control II assay was carried out when only
n-HA powder was added to the peptone solution. The
concentration of the samples was 1 g/mL. [Color ﬁgure
can be viewed in the online issue, which is available at
www. interscience.wiley.com.]
TABLE III
Results of the Antibacterial Rates of the n-HA/ZnO
Composite Against Bacteria
Antibacterial Rate (%)
Under Light Without Light
E. coli (2.1 3 106 cfu/mL) 95.65 87.48
S. aureus (1.9 3 106 cfu/mL) 99.45 91.32
Note: cfu denotes colony forming unit; 2.1 3 106 cfu/
mL, 1.9 3 106 cfu/mL are the concentration of bacteria
used in antibacterial test experiments.
Figure 10. Agarose gel electrophoresis cleavage reaction
of E. coli’s DNA by the dissolving solution of materials
with different time (ethidium bromide staining). Lane 1:
Control I, A control I assay was carried out without mate-
rial; Lane 2: Control II, A control II assay was preformed
when only n-HA contacted with pUC18 for 300 min; Lanes
3–9: n-HA/ZnO complex was contacted with pUC18 at 1,
5, 10, 15, 30, 60, and 300 min.
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CONCLUSION
n-HA/ZnO complex possesses a nanometer size,
and the size, composition as well as structure of n-
HA change little during complexation. The lattice
parameters, a and c, of both n-HA and ZnO change
after compounding. Zn2þ ions of ZnO can enter the
n-HA crystal lattice. The n-HA/ZnO complex has a
good antibacterial activity, which is 98.65% and
99.45% against E. coli and S. aureus under light,
respectively, and the antibacterial activity for S. aureus
is stronger than that for E. coli. The occurrence of
antibacterial capability is supposed to be due to the
generation of active oxide from the surface of com-
plex and Zn2þ or OH, which can cleave the 3,5-
phosphate diester bond, inducing the decomposition
of bacteria.
The approach as used in the current study pro-
duced a complex with good antibacterial activity
properties without sacriﬁcing biocompatibility. The
resulting HA-based system holds wide potential for
application in clinic as an antibacterial biomaterial,
as well as for dental ﬁling and repair.
The authors thank Mr. Chen Shitu for XRD data and
Ms. Zhu Xiaohong for IR data.
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